DOI QR코드

DOI QR Code

A Methocarbamol Combination to Prevent Toxicity of Non-steroidal Anti Inflammatory Drugs

비스테로이드성 항염증제의 약물독성 예방을 위한 Methocarbamol의 약물조합

  • Yeom, Seung-Min (USFK, Army 2nd Infantry Division, Camp Hovey Combined Troops Medical Aid Station) ;
  • Kim, Min-Seok (USFK, Army 2nd Infantry Division, Camp Hovey Combined Troops Medical Aid Station) ;
  • Lingenfelter, Eric (USFK, Army 2nd Infantry Division, Camp Hovey Combined Troops Medical Aid Station) ;
  • Broadwell, Jonathan (Army National Guard, University of Utah School of Medicine)
  • 염승민 (주한미군 육군 제2보병사단 캠프호비 클리닉) ;
  • 김민석 (주한미군 육군 제2보병사단 캠프호비 클리닉) ;
  • ;
  • Received : 2017.03.14
  • Accepted : 2017.04.17
  • Published : 2017.06.30

Abstract

To prevent toxicity from both robax platinum (methocarbamol, ibuprofen) and robaxacet (methocarbomol, acetaminophen), separately, we used stretches and naproxen as a non-steroidal anti-inflammatory drug (NSAID) to compare each effectiveness. This study used the United States Forces Korea Prescription form (Annex A-Over-The-Counter Prescription) and Alice Rich's Pain scale with robax platinum, robaxacet including narproxen. The IBM SPSS statics version 24 was used to calculate the data. The combined methocarbamol 500 mg, acetaminophen 325 mg tablet, and ibuprofen 200 mg (or naproxen) tablet can work as well as the combined methocarbamol 500 mg tablet with acetaminophen 325 mg tablet with stretches. Both methods were successful in managing pain. The drug combination of methocarbamol 500 mg, acetaminophen 325 mg and ibuprofen 200 mg tablets yielded similar benefits as the methocarbamol 500 mg and acetaminophen 325 mg tablets paired with physical stretching exercises regarding managing overall pain.

비 스테로이드성 항염증제에 대한 개별적 독성증상을 예방하기 위해 로박스 플라티넘(Robax Platinum), 로박스아세트(Robaxacet), 나프록센(Naproxen) 그리고 재활치료를 선택적으로 처방하여 비 스테로이드 진통소염제(Non-Steroidal Anti-Inflammatory Drugs)에 대한 독성증상을 예방을 위한 효과 비교 연구를 진행하였다. 이 연구에서는 로박스 플라티넘(Robax platinum), 로박스아세트(Robaxacet), 나프록센(Naproxen)을 주한미군 처방전(Annex A-Over-The-Counter Prescription)을 기준으로 하여 처방하였고, 앨리스 리치의 통증 척도(Alice Rich's Pain Scale)를 사용하여 통증 경과를 비교하고 그 결과를 IBM SPSS statics 24 버전을 사용하여 데이를 계산했다. 결합된 메토카바몰(Methocarbamol, 500 mg), 아세트아미노펜(Acetaminophen, 325 mg), 이부프로펜(Ibuprofen, 200 mg) 정제는 결합된 메토카바몰(Methocarbamol, 500 mg) 정제와 함께 사용할 수 있다. 아세트아미노펜 (Acetaminophen, 325 mg)의 알약이 통증을 조절하는 방법으로 사용되었다. 메도카바몰 500mg, 아세트아미토펜 325 mg 및 이부프로펜 200 mg 정제의 약물 조합은 메도카바몰 500 mg 및 아세트아미노펜 325 mg 정제가 전반적인 통증 조절과 관련하여 물리적인 스트레칭 운동과 쌍을 이룬 것과 유사한 통증 완화효과를 나타내었다.

Keywords

References

  1. Nicholson JK, Connelly J, Lindon JC, Holmes E. Platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1(2):153-161. https://doi.org/10.1038/nrd728
  2. Alam MJ, Alam O, Khan SA, Naim MJ, Islamuddin M, Deora GS. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Drug Des Dev Ther. 2016;10:3529-3543. https://doi.org/10.2147/DDDT.S118297
  3. Jung JY, Park MH, Park HJ, Shim SB, Cho YH, Kim JH, et al. Hydrogen NMR-based metabolic profiling of naproxen-induced toxicity in rats. Toxicology Letters, 2011;200(1):1-7. https://doi.org/10.1016/j.toxlet.2010.09.020
  4. Sanwal V, Pandya M, Bhaskaran M, Franki N, Reddy K, Ding G, et al. Puromycin aminonucleoside induces glomerular epithelial cell apoptosis. Exp Mol Pathol. 2001;70(1):54-64. https://doi.org/10.1006/exmp.2000.2345
  5. Flamenbaum W. Uranyl nitrate-induced acute renal failure in the rat: Micropuncture and renal hemodynamic studies. Kidney Int Rep. 1974;6(6):408-418. https://doi.org/10.1038/ki.1974.126
  6. Peter HY, Davisa BA, Denga Y. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase. Biochem Pharm. 2001;61(6):741-748. https://doi.org/10.1016/S0006-2952(01)00524-X
  7. Wideman GL, Keffer M, Morris E, Doyle RT, Jiang JG, Beaver WT, et al. Analgesic efficacy of a combination of hydrocodone with ibuprofen in postoperative pain. CPT Pharmacometrics Syst Pharmacol. 1999;65(1):66-76.
  8. Lucile Packard Children's Hospital Heart Center. 0 - 10 Comparative pain scale [Internet]. Standford: Palo alto; 2016 [cited 2016 May 14]. Available from: https://lane.stanford.edu/portals/cvicu/HCP_Neuro_Tab_4/0-
  9. Bruce RB, Turnbull LB, Newman JH. Metabolism of methocarbamol in the rat, dog, and human. J Pharm Sci. 1971;60(1):104-106. https://doi.org/10.1002/jps.2600600120
  10. Prescott, LF. Paracetamol (acetaminophen). 1st ed. Boca Raton: CRC press; 1996. p140-156.
  11. Fortuny J, Kogevinas M, Garciaclosas M. Real FX, Tardon A, Garciaclosas R, et al. Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain. Cancer Epidemiology. 2006;15(9):1696-1702.
  12. Hamman MA, Thompson GA, Hall SD, Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem Pharmacol. 1997;54(1):33-41. https://doi.org/10.1016/S0006-2952(97)00143-3
  13. Neunzig I, Gohring A, Dragan CA, Zapp J, Peters FT, Maurer HH, et al. Production and NMR analysis of the human ibuprofen metabolite 3-hydroxyibuprofen. J Biotechnol. 2012;157(3):417-420. https://doi.org/10.1016/j.jbiotec.2011.12.016
  14. Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998;34(2):101-154. https://doi.org/10.2165/00003088-199834020-00002
  15. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci. 1984;81(5):1327-1331. https://doi.org/10.1073/pnas.81.5.1327
  16. Dong H, Haining RL, Thummel KE, Rettie AE, Nelson SD. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab Dispos. 2000; 28(12):1397-1400.
  17. Raucy JL, Lasker JM, Lieber CS, Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochemd Biophys. 1989;271(2):270-283. https://doi.org/10.1016/0003-9861(89)90278-6
  18. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp. 1973;187(1):195-202.
  19. Lai MW, Klein-Schwartz W, Rodger GC, Abrams JY, Haber DA, Bronstein AC, et al. 2005 Annual Report of the American Association of Poison Control Centers' National Poisoning and Exposure. Cli Toxic, 2006;44:803-932. https://doi.org/10.1080/15563650600907165
  20. Drug dot com. Acetaminophen dosage [Internet]. Washington DC: Cerner Multum; 2016 [cited 2016 May 10]. Available from: https://www.drugs.com/dosage/acetaminophen.html.
  21. Drug dot com. Naproxen dosage [Internet]. Washington DC: Cerner Multum; 2016 [cited 2016 May 10]. Available from: https://www.drugs.com/dosage/naproxen.html.
  22. Thomas ED. Exercise in the Management of Chronic Back Pain. Ochsner J. 2014; 14(1):101-107.
  23. Drug dot com. Methocarbamol dosage [Internet]. Washington DC: Cerner Multum; 2016 [cited 2016 May 10]. Available from: https://www.drugs.com/pro/methocarbamol.html.
  24. Hinson JA, Roberts DW, Benson RW, Dalhoff K, Loft S, Poulsen HE. Mechanism of paracetamol toxicity. Lancet. 1990;335(8691):732.
  25. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis. Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302-1308. https://doi.org/10.1136/bmj.332.7553.1302
  26. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol. 2009;44(19):23-29. https://doi.org/10.1007/s00535-008-2266-6
  27. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520-1528. https://doi.org/10.1056/NEJM200011233432103
  28. Mansuy D. Metabolism of xenobiotics with beneficial and adverse effects. Biol Aujourdhui. 2013;207(1):33-37. https://doi.org/10.1051/jbio/2013003
  29. Kenney WL, Wilmore J, Costill D. Physiology of sport and exercise. 6th ed. Champaign: Human kinetics; 2015. p213-218.